Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Research & Development (2017 - 2026)

Neuronetics has reported Research & Development over the past 10 years, most recently at $1.4 million for Q1 2026.

  • Quarterly Research & Development fell 15.59% to $1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Mar 2026, down 47.4% year-over-year, with the annual reading at $6.6 million for FY2025, 48.45% down from the prior year.
  • Research & Development was $1.4 million for Q1 2026 at Neuronetics, down from $1.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $5.8 million in Q4 2024 and troughed at $1.4 million in Q1 2026.
  • The 5-year median for Research & Development is $2.2 million (2023), against an average of $2.3 million.
  • Year-over-year, Research & Development surged 161.53% in 2024 and then tumbled 71.14% in 2025.
  • A 5-year view of Research & Development shows it stood at $3.1 million in 2022, then dropped by 29.69% to $2.2 million in 2023, then surged by 161.53% to $5.8 million in 2024, then tumbled by 71.14% to $1.7 million in 2025, then fell by 18.13% to $1.4 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Research & Development are $1.4 million (Q1 2026), $1.7 million (Q4 2025), and $1.5 million (Q3 2025).